english.prescrire.org > Spotlight > Archives : 2013 > In the April issue of Prescrire International: Prescrire's editors look back at new drugs and new indications in 2012

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2013 : 1 | 30 | 60

In the April issue of Prescrire International: Prescrire's editors look back at new drugs and new indications in 2012

FREE DOWNLOAD The therapeutic advances identified by the editors of independent French journal Prescrire in 2012 were minimal. And 15 new drugs or indications reviewed during the past year are actually dangerous.
Full text available for free download.

Abstract

  • The therapeutic advances identified in 2012 were minimal, and 15 new drugs or indications are dangerous.
     
  • The dearth of improvement in patient care contrasts with the sometimes disproportionately high prices agreed upon for drugs, especially in oncology.
     
  • The few steps taken by health authorities that benefited patients, mainly by withdrawing or revoking reimbursement for drugs with an unfavourable harm-benefit balance, were insufficient in view of the constant pressure from the pharmaceutical industry to sell ever more drugs.

Full text available for free download below.

 HTML  Full text also available free online

 ©Prescrire 1 April 2013

"New drugs and indications in 2012. Sluggish progress, timid measures to protect patients" Prescrire Int 2013; 22 (137): 105-107. (Pdf, free)
Download the full review
Pdf, free

Read full article online
Free

See also:

Towards better patient care:
drugs to avoid
(April 2013)
Free